OGENORAGENICS INCvs its industry peers
A metric-by-metric comparison of ORAGENICS INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OGENEsta | $2M#5 | 0.5x#3 | 0.6x#3 | 58.7x#3 | -71.4%#3 | 6.9%#4 | -24865.2%#3 | -26814.1%#4 | — | — | — | — |
| ONCO | $3M#1 | 0.0x#1 | 0.2x#1 | 3.2x#2 | -67.7%#2 | 76.1%#2 | -2190.0%#2 | -104.2%#2 | — | — | -99.6%#4 | — |
| JUNS | $2M#2 | — | — | 112.9x#4 | — | -254.4%#6 | -40873.2%#4 | — | — | — | -97.3%#3 | — |
| ZVSA | $2M#3 | — | — | — | — | -165.1%#5 | — | — | — | — | -45.1%#1 | — |
| MTNB | $2M#4 | — | 1.3x#4 | 2.1x#1 | -65.6%#1 | 57.3%#3 | -635.0%#1 | -574.7%#3 | — | — | -90.7%#2 | — |
| DCOY | $2M#6 | 0.0x#2 | 0.4x#2 | — | -100.0%#4 | 124.4%#1 | — | 289.8%#1 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice